Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Mar 20, 2023

BUY
$0.42 - $1.48 $84 - $296
200 New
200 $294,000
Q1 2022

Mar 21, 2023

BUY
$1.06 - $2.68 $212 - $536
200 New
200 $230,000
Q4 2021

Mar 21, 2023

BUY
$2.5 - $5.19 $500 - $1,038
200 New
200 $500,000
Q3 2021

Mar 22, 2023

BUY
$4.82 - $8.46 $964 - $1,692
200 New
200 $1.02 Million
Q2 2021

Mar 22, 2023

BUY
$6.81 - $9.71 $1,362 - $1,942
200 New
200 $1.66 Million
Q1 2021

Mar 22, 2023

BUY
$7.45 - $12.32 $1,490 - $2,464
200 New
200 $1.74 Million
Q4 2020

Mar 22, 2023

BUY
$10.34 - $13.77 $2,068 - $2,754
200 New
200 $2.17 Million
Q3 2020

Mar 22, 2023

BUY
$11.73 - $16.25 $2,346 - $3,250
200 New
200 $2.39 Million
Q1 2020

Mar 24, 2023

BUY
$14.83 - $26.72 $2,966 - $5,344
200 New
200 $3.1 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.